Tag Archives: National Institutes of Health

NIH Licensing Efforts Target Start-Ups

NIH_Logo

The National Institutes of Health (NIH) has developed a new short-term licensing arrangement they hope will encourage licensing of NIH and FDA inventions to start-up companies.  The NIH Start-Up Exclusive License Agreements targets start-up companies less than 5 years old, with less than $5M in raised capital, and fewer thans than 50 employees.  By offering an exclusive license, they hope to accelerate the technology transfer process.  However, this temporary pilot program runs only until September 30, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

NIH: Streamlining the Technology Transfer Process

cyclotron

The National Institutes of Health (NIH) is launching the electronic Research Materials catalogue (eRMa) to streamline the federal government’s technology transfer process. “To stay competitive in today’s world, on-line ordering is a requirement. With the launch of this first-of-its kind system, OTT is demonstrating its intention to meet that challenge,” said Mark Rohrbaugh, director of OTT. According to the press release: “The new system will streamline the licensing process by: Providing a website for companies Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , ,

Moving Beyond the Stem Cell Stalemate

Michael Werner

By Michael J. Werner, Alliance for Regenerative Medicine For the past several years, attendees at the World Stem Cell Summit have focused their energies primarily on legislative and legal efforts to protect human embryonic stem cell research. When folks gather at this year’s meeting, they will once again confront the reality that research opponents will continue to try to block these efforts. James Sherley has filed an appeal to the US Court of Appeals, DC Circuit Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Tech Transfer Summit North America

Tech Transfer Summit

The National Institutes of Health, BIO, and others are sponsoring the Tech Transfer Summit North America at NIH on 3-4 October 2011. Programming includes Translational Medicine & Funding Innovation, Successful Implementation of Biotech Innovation Strategies Worldwide, and Building Better Academia-Industry Collaborations: How will Big Pharma fill its early-stage Pipeline in 5 years’ time, among other topics. BIO’s President and CEO James C. Greenwood will give one keynote speach on the ”Barriers to Innovation in biotechnology, and Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Survey on Technology Transfer Shows Complexity of University-Industry Relationships

I sat down with Cartier Esham, Director, Emerging Company Health and Regulatory Affairs at BIO, to discuss BIO’s new survey on licensing trends between universities and companies, part of a larger process of technology transfer. BIO will release the survey at this year’s BIO Investor Forum Technology Transfer Symposium, October 28, 2009. You can learn more about by visiting www.bio.org/ip/techtransfer.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,